# PHARMACEUTICS/FORMULATION/CMC CONSULTING SERVICES FOR NINDS HEAL PROGRAM

> **NIH NIH N02** · — · 2024 · $7,877

## Abstract

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.

CMC / Pharmaceutics / Formulation 

CMC / Pharmaceutics / Formulation consultants will be expected to provide senior-level CMC / Pharmaceutics / Formulation expertise and contribute feedback and guidance on projects to the NIH and to LDT members through conference calls and by email. The role of the CMC / Pharmaceutics / Formulation consultant may include but is not limited to the following responsibilities and tasks:

•	Evaluate Chemical Manufacturing and Controls [CMC] activities for compounds under development in accordance with US regulatory and International Council of Harmonization for Registration of Pharmaceuticals for Human Use [ICH] guidelines.
•	Identify and assess regulatory risks for compounds under development and provide CMC guidance to NINDS and LDTs. Develop CMC strategies which accord with US and international guidelines.
•	Provide recommendations for drug substance manufacturing, analytical method development, and process development for small molecules.
•	Provide pharmaceutical sciences expertise in chemical manufacturing, formulation, and product development for small molecules.
•	Assist in ensuring timely preparation, review, and submission of chemical manufacturing and controls documents to regulatory authorities including FDA, European Medicines Agency [EMA] and other national authorities, to support the conduct of clinical trials and marketing applications.
•	Provide expertise in activities related to API development.
•	Recommend dose form selection and API development strategies for NINDS efforts.
•	Develop plans to assist NIH staff in strategically managing chemical manufacturing and controls pharmacokinetic programs which facilitate assay development, exploratory chemistry, lead optimization, formulation activities, investigational new drug (IND) enabling, and clinical studies.
•	Accompany NIH staff or visit, at NIH staff request, Contract Research Organizations [CRO] under contract with NIH. Inspect facilities and discuss appropriateness of CRO proposed methodology. Submit trip reports to NIH staff.
•	Assist NIH staff to design investigative chemical manufacturing and controls pharmacokinetics studies, including study strategy and experimental design. Provide advice regarding recommended study milestones and prepare milestone reports as needed.
•	Facilitate Lead Development Team discussions via telephone and email regarding assigned drug metabolism and pharmacokinetics efforts.
This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management. It’s part of the program that establishes novel treatment options for a variety of pain conditions to improve quality of life and reduce opioid dependency.  The program studies a ...

## Key facts

- **NIH application ID:** 11166253
- **Project number:** 75N95021P00690-P00005-0-1
- **Recipient organization:** —
- **Principal Investigator:** SOMNATH MISHRA
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $7,877
- **Award type:** —
- **Project period:** 2021-09-29 → 2024-09-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11166253

## Citation

> US National Institutes of Health, RePORTER application 11166253, PHARMACEUTICS/FORMULATION/CMC CONSULTING SERVICES FOR NINDS HEAL PROGRAM (75N95021P00690-P00005-0-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11166253. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*